As for studies in humans, the possible decrease in cholesterol synthesis to explain the alleged cardioprotective effect of G6PD deficiency was proposed by Long et al
[DOI] [PMC free article] [PubMed] [Google Scholar] 94.Iyer P.S., Rishitha Yelisetti R., Miriyala V., Siddiqui W., Kaji A
doi: 10.1634/theoncologist.2013-0333 38
I'm Michael Zezas, Global Head of Fixed Income Research and Public Policy Strategy
A supervised trial of berberine and semaglutide is generally not a good idea if you: Have a history of severe hypoglycemia Have advanced liver or kidney disease Are pregnant, planning pregnancy, or breastfeeding Have complex polypharmacy (multiple meds that rely on CYP3A4/CYP2D6) Have a history of pancreatitis or serious GI motility disorders (which already restrict semaglutide use) If any of these apply, talk with your clinician about safer alternatives
[26] Es importante trabajar con su proveedor de atencin mdica para establecer objetivos glucmicos personalizados y determinar la frecuencia apropiada de monitoreo